Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 16304565Search this ID in NIH RePORTER
- ScienceDex PI coverage
- FY2024 through FY2025Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
NIH Funding · FY2024
Linked Award Amount
$1.3M
Full award amounts, FY2024
Award Records
2
Records listing this PI
Award-Linked Rank
#10,689
By linked amount among FY2024 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2024 award records by amount
NIH award records listing Maria Constance Athanasiou as a PI. Multi-PI records show the full award amount for context.
- 4R42AI167175-02R42A novel CAR-T cell therapy for the one-time treatment of chronic HIV infection in patients who are not ART suppressed$1Maward amount
- 1R41AI184054-01R41Proof of concept studies for in vivo produced CAR-T cells that target B cell follicles as a treatment for HIV$302.2Kaward amount
Award organization
Organizations that administered FY2024 awards listing Maria Constance Athanasiou as a PI.
FY2024 award administered by Marpam Pharma, LLC (MN).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardMarpam Pharma, LLC
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2025$2M Cumulative Funding
Shared-award investigators
Other investigators listed on at least one of the same NIH award records as Maria Constance Athanasiou.